Skip to main content
OpenTrials
Completed

NCT Number: NCT04031131

The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids

The investigators' aim is to assess if they can complete a study measuring the effect of local anaesthetic gel (Instillagel) on reducing pain experienced by patients undergoing a common treatment for haemorrhoids (piles). This treatment is called rubber band ligation and is commonly performed in the investigators'clinics.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Norfolk & Norwich University Hospitals NHS Foundation Trust

Norwich, Norfolk, NR4 7UY, United Kingdom

About this study

A feasibility trial assessing patient recruitment, retention, randomization, and surgeon acceptability of topical anaesthetic use during rubber band ligation of haemorrhoids.

A patient and assessor blinded feasibility trial. The trial population will prospectively be recruited from colorectal surgery outpatients. Patients will be randomized to two groups to receive: lubricating gel (K-Y Jelly) and topical anaesthetic gel (Instillagel) or lubricating gel alone (the standard care).

The intervention group will receive lubricating gel and topical anaesthetic gel (containing lidocaine active ingredient) administered rectally, whilst the control group will receive lubricating gel alone (standard care). This will be carried out in Colorectal Outpatients. The band ligation of the haemorrhoids should occur between 5-10 minutes after administration of the topical anaesthetic/lubricating gel. Pain scores and the use of oral analgesia will be measured immediately after the procedure (5 minutes), upon leaving the clinic (approximately 30 minutes after), at 4 hours, and 72 hours following the procedure. Vasovagal symptoms or other complications will be recorded whilst the patient is in the clinic. At 1 month post procedure, patients will be phoned to determine if any adverse events have occurred.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Symptomatic grade 1-3 haemorrhoid disease, 18+ years old, English is the first language.

Exclusion criteria

  • Allergy to active ingredients of Instillagel, Allergy to local anaesthetic, Chronic liver disease, Grade 4 haemorrhoid disease, Pregnancy, Inflammatory bowel disease, Pre-existing anorectal disease.

Treatment and study plan

Instillagel

Drug

Topical Anaesthetic Gel (Instillagel) licensed for rectal administration.

KY Gel

Other

Lubricant Gel

Primary outcomes

  1. Patient recruitment rate

    Time frame: 5 months

    Patient recruitment rate via screening log.

  2. Treatment acceptability to patients

    Time frame: 5 months

    Treatment acceptability to patients via study questionnaire. A visual analogue scale to be used, 0 - 10 with '0' being no pain and '10' being worst pain possible.

  3. Patient retention

    Time frame: 5 months

    Patient retention via recruitment log.

Secondary outcomes

  1. Assess if the intervention reduced pain associated with haemorrhoids up to 72 hours after the procedure,

    Time frame: 72 hours

    Assess if the intervention reduced pain associated with haemorrhoids up to 72 hours after the procedure via study questionnaire.

  2. Assess if the intervention reduces vasovagal symptoms up to 72 hours after the procedure

    Time frame: 72 hours

    Assess if the intervention reduces vasovagal symptoms up to 72 hours after the procedure via study questionnaire.

  3. Assess if the intervention reduced oral analgesia burden following the procedure

    Time frame: 72 hours

    Assess if the intervention reduced oral analgesia burden following the procedure via study questionnaire.

  4. Assess hospital readmission 1 month after the procedure.

    Time frame: 1 month

    Assess hospital readmission 1 month after the procedure via review of hospital notes. The number of patients requiring additional analgesia will be compared between the two groups.

Sponsors and collaborators

Lead sponsor

Julie Dawson

Other

Registry information

Official study title

The Use of Topical Anaesthetic in the Banding (TAB) of Internal Haemorrhoids: A Feasibility Study.

Acronym: TAB

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jul 24, 2019
Registry last updated
Oct 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.